OCLASSEN GLENN A 4
4 · Transcept Pharmaceuticals Inc · Filed Feb 2, 2012
Insider Transaction Report
Form 4
OCLASSEN GLENN A
DirectorPresident and CEO
Transactions
- Award
Employee Stock Option (right to buy)
2012-02-01+180,000→ 180,000 totalExercise: $8.09Exp: 2022-02-01→ Common Stock (180,000 underlying)
Footnotes (1)
- [F1]The option vests in forty-eight equal monthly installments beginning on March 1, 2012.